Evidence map›Paper›PMID 40389710›Full record

ArticleProstate cancer and prostatic diseases2026

Perioperative outcomes of HoLEP, ThuLEP, and TURP in patients with prostate cancer: results from the GRAND study.

Nikolaos Pyrgidis, Gerald Bastian Schulz, Philipp Weinhold, Michael Atzler, Leo Federico Stadelmeier, Iason Papadopoulos, Christian Stief, Julian Marcon, Patrick Keller

Abstract read
In one paragraph

Article in Prostate cancer and prostatic diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nikolaos PyrgidisDepartment of Urology, University Hospital LMU, Munich, Germany. Nikolaos.pyrgidis@med.uni-muenchen.de.ORCID http://orcid.org/0000-0002-7707-8426
Gerald Bastian SchulzDepartment of Urology, University Hospital LMU, Munich, Germany.ORCID http://orcid.org/0000-0002-0340-0304
Philipp WeinholdDepartment of Urology, University Hospital LMU, Munich, Germany.
Michael AtzlerDepartment of Urology, University Hospital LMU, Munich, Germany.
Leo Federico StadelmeierDepartment of Urology, University Hospital LMU, Munich, Germany.
Iason PapadopoulosDepartment of Urology, University Hospital LMU, Munich, Germany.
Christian StiefDepartment of Urology, University Hospital LMU, Munich, Germany.
Julian MarconDepartment of Urology, University Hospital LMU, Munich, Germany.
Patrick KellerDepartment of Urology, University Hospital LMU, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLimited data exist on the role of holmium laser enucleation of the prostate (HoLEP), thulium laser enucleation of the prostate (ThuLEP), and transurethral resection of the prostate (TURP) in patients with prostate cancer (PCa). We aimed to analyze their perioperative outcomes and trends. MATERIALS AND

methodsThe German Nationwide Inpatient Data (GRAND) registry was used to identify male patients diagnosed with PCa who underwent HoLEP, ThuLEP, or TURP between 2005 and 2022. Multivariable regression analyses were performed to compare perioperative morbidity and mortality.

resultsA total of 221,768 procedures in patients with PCa were performed: 8160 HoLEP, 2285 ThuLEP, and 211,323 TURP. Although TURP remains the predominant technique, the use of HoLEP and ThuLEP has increased significantly in recent years, representing 17% of all cases by 2022. Perioperative outcomes were worse for TURP, with higher transfusion (8.8%) and ICU admission rates (1.7%) compared to HoLEP and ThuLEP (both 2.5% and ≤1.2%, respectively). Postoperative urinary retention and incontinence rates were also lower for laser enucleation techniques than TURP. In patients with PCa undergoing TURP, perioperative outcomes were worse compared to those without PCa, while outcomes for HoLEP and ThuLEP were comparable regardless of PCa status.

conclusionHoLEP and ThuLEP offer improved perioperative outcomes compared to TURP in patients with PCa.

Indexed as

Lasers, Solid-StateLaser TherapyPostoperative ComplicationsProstatectomyProstatic NeoplasmsTransurethral Resection of ProstateAgedAged, 80 and overGermanyHumansMaleMiddle AgedRegistriesThuliumTreatment OutcomeThulium

Identifiers

PMID40389710
PMCPMC12909125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.